Silicon Valley Bank Expands Life Science & Healthcare Team

Silicon Valley Bank (NASDAQ:FCNCA) expanded its Life Science & Healthcare team on May 7, 2026, adding six senior hires across New York, San Francisco, and Boston to strengthen clinical, venture and private‑credit expertise.

Rhea-AI Summary

Silicon Valley Bank (NASDAQ:FCNCA) expanded its Life Science & Healthcare team on May 7, 2026, adding six senior hires across New York, San Francisco, and Boston to strengthen clinical, venture and private‑credit expertise. The practice will remain focused on healthtech, biotech, diagnostics, tools and startup banking as SVB rebrands to First Citizens Innovation Banking in Q4 2026.

Argus May 7 session

-1.90% close to close Open Argus

Details

News Market Reaction – FCNCA

On May 7, the day this news came out, FCNCA closed 1.90% below the previous close.

Data tracked by StockTitan Argus for the May 7 session.

Market Context

This announcement highlights further build-out of First Citizens’ Life Science & Healthcare capabili...

Analysis

This announcement highlights further build-out of First Citizens’ Life Science & Healthcare capabilities, adding 6 specialists and reinforcing its innovation-economy focus ahead of the planned Q4 2026 rebrand to First Citizens Innovation Banking. In recent months, the company reported solid earnings, expanded commercial solutions, and grew key credit relationships. Investors monitoring this theme may focus on how specialized teams translate into loan growth, fee income, and client retention within healthtech, biotech, diagnostics, and tools over time.

Key Figures

New team members: 6 experts Planned rebrand timing: Q4 2026

New team members

6 experts

Life Science & Healthcare team expansion at SVB division

Planned rebrand timing

Q4 2026

SVB division to rebrand as First Citizens Innovation Banking

Historical Context

5 past events · Latest: May 05

5 events

1. May 05

   Credit facility expansion

   24h Move

   +2.4%

   Upsized and renewed Parafin warehouse credit facility with SVB and lenders.

2. Apr 23

   Q1 2026 earnings

   24h Move

   -3.4%

   Reported strong earnings, balance sheet growth, buybacks and note prepayment.

3. Apr 23

   Brand and solutions expansion

   24h Move

   -3.4%

   Announced rebranding of SVB-related units and expanded commercial capabilities.

4. Apr 23

   Dividend declaration

   24h Move

   -3.4%

   Declared quarterly common and preferred dividends payable in June 2026.

5. Apr 21

   Regional leadership change

   24h Move

   -0.4%

   Appointed new South Region executive overseeing 55 branches and growth efforts.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Group adds 6 experts

SAN FRANCISCO, May 7, 2026 /PRNewswire/ -- Expanding its already deep bench of sector expertise, Silicon Valley Bank (SVB), a division of First Citizens Bank, announced it has added several new hires to its Life Science and Healthcare team. The expansion of the team further reinforces SVB's ongoing commitment to partnering with and financing companies across the innovation economy, in sectors such as healthtech, biotech, diagnostics and tools.

Through its nationwide Life Science and Healthcare practice, the SVB division provides specialized banking services, debt-financing solutions, a vast network of professional connections, and sector insights to companies and investors across the industry.

"Our new team members bring diverse expertise to our clients and reinforce our ongoing investment in our Life Science and Healthcare practice," said Megan Scheffel, Head of Life Science and Healthcare at Silicon Valley Bank, a division of First Citizens Bank. "By intentionally adding deep clinical and venture expertise and experience in the private credit sector, we are providing our clients with more specialized industry support and access to financial solutions that help them navigate and succeed in an increasingly complex healthcare sector."

The recent hires span a variety of roles:

• Bill Burkoth, Senior Managing Director for the Life Science and Healthcare team's East Region, based in New York.
• Bryce Bewley, Managing Director for Life Science and Healthcare, based in San Francisco.
• Ryan Martin, Director for the NorCal Biotechnology, Diagnostics, and Tools Relationship Management Team, based in San Francisco.
• Gibson Cooper, Vice President for the NorCal HealthTech and MedTech Credit Solutions Team, based in San Francisco.
• Wendy Chan, Director for Life Science and Healthcare Startup Banking, based in San Francisco.
• Ries McQuillan, Director for Life Science and Healthcare Startup Banking, based in Boston.

Read more about the Silicon Valley Bank division's Life Science and Healthcare practice here: Global Life Science and Healthcare.

Silicon Valley Bank, a division of First Citizens Bank, recently announced its plans to rebrand as First Citizens Innovation Banking in Q4 2026. The Life Science & Healthcare practice will remain dedicated to the sector.  

About Silicon Valley Bank 

Silicon Valley Bank (SVB), a division of First Citizens Bank, is the bank of some of the world's most innovative companies and investors. SVB provides commercial banking to companies in the technology, life science and healthcare, private equity and venture capital industries. SVB operates in centers of innovation throughout the United States, serving the unique needs of its dynamic clients with deep sector expertise, insights and connections. SVB's parent company, First Citizens BancShares, Inc. (NASDAQ: FCNCA), is a top 20 U.S. financial institution with more than $225 billion in assets. First Citizens Bank, Member FDIC. Learn more at svb.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/silicon-valley-bank-expands-life-science--healthcare-team-302765301.html

SOURCE Silicon Valley Bank

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who did Silicon Valley Bank (FCNCA) add to its Life Science & Healthcare team on May 7, 2026?

Six senior hires joined the practice, including leaders in New York, San Francisco, and Boston. According to Silicon Valley Bank, the new hires include Bill Burkoth, Bryce Bewley, Ryan Martin, Gibson Cooper, Wendy Chan, and Ries McQuillan, covering regional and specialty roles.

What roles and locations were announced in the SVB Life Science & Healthcare expansion for FCNCA?

New roles include senior managing director, managing director, directors, and vice president across East, NorCal, and Boston. According to Silicon Valley Bank, hires are based in New York, San Francisco, and Boston, covering biotech, diagnostics, healthtech, medtech, and startup banking.

How will the new SVB hires affect Life Science & Healthcare services for FCNCA clients?

The hires are intended to broaden clinical, venture and private‑credit expertise available to clients. According to Silicon Valley Bank, the expanded team aims to provide specialized banking, debt solutions, networks, and sector insights for healthtech, biotech, diagnostics and tools companies.

Will the SVB Life Science & Healthcare practice change after SVB rebrands to First Citizens Innovation Banking?

The practice will remain dedicated to the sector despite the rebrand planned for Q4 2026. According to Silicon Valley Bank, the Life Science & Healthcare team will continue focusing on specialized services and financing under the First Citizens Innovation Banking name.

Does the SVB announcement for FCNCA include financial guidance or deal values?

No financial guidance, revenue figures, or deal values were disclosed in the hiring announcement. According to Silicon Valley Bank, the release describes team expansion and service capabilities but does not report specific financial metrics or transaction amounts.